Pharma’s Public Pledge On COVID-19 Vaccines
On Sept. 8, 2020, nine pharmaceutical companies working on COVID-19 vaccines signed a pledge saying they would not submit their experimental vaccines to the U.S. Food and Drug Administration (FDA) unless they were shown to be both safe and efficacious in the Phase 3 human clinical trials.1 2 3 4 5 The pledge, signed by […]
Will Newborns Be Separated from Parents for COVID-19 Testing?
Opinion | The Bill & Melinda Gates Foundation is the biggest funder of vaccines in the entire world and, according to Gates, its COVID-19 vaccination effort “dwarfs anything we’ve ever worked on before.”1 Indeed, Gates push for mandatory COVID-19 vaccination—and investment in those vaccines—is historically unprecedented. In an Apr. 30, 2020 GatesNotes post,2,3 Gates even […]
Virginia Legislature Gives CDC, Board of Health Power to Mandate Vaccines for School Children
In the 2020 Legislative session, the Virginia Legislature passed H.B.1090, a bill that amended a law requiring children attending public and private schools in the state to receive vaccines (§ 32.1-46. Immunization of patients against certain diseases).1 Virginia Delegate Patrick Hope (D-Arlington) was the lead sponsor of H.B. 1090 introduced on Jan. 8, 2020, which […]
GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant
Story Highlights GlaxoSmithKline and Sanofi Pasteur are partnering to develop an experimental COVID-19 vaccine. The two global vaccine manufacturers are using existing recombinant DNA vaccine technology and a squalene adjuvant for their COVID-19 vaccine. Clinical trials are scheduled to begin in the second half of 2020 and, if successful, the vaccine will be available in […]
COVID-19 Meltdown and Pharma’s Big Money Win
Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases (NIAID) told Americans on Apr. 1, 2020 that modeling reports suggested COVID-19 infections could eventually “kill 100,000 to 240,000 Americans,”1 2 3 which was considerably less than the worst case 1.7 million mortality figure the Centers for Disease Control and Prevention (CDC) […]
Tamiflu on Track to Be an Over-The-Counter Drug
In July 2019, drug and French vaccine manufacturer Sanofi signed a deal with Roche Pharmaceuticals to obtain exclusive over-the-counter (OTC) rights for Tamiflu (oseltamivir), an antiviral drug licensed for the treatment of influenza infections. Genentech, a member of the Roche Group, currently sells Tamiflu in the United States only for prescription use.1 Tamiflu is a […]
